750
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma

, , & ORCID Icon
Pages 1051-1059 | Received 23 Oct 2019, Accepted 24 Sep 2020, Published online: 01 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Shefali Singh, Deevanshu Goyal, Karthikeyan Raman, Sachin Kumar, Prabhat Singh Malik & Ravikrishnan Elangovan. (2023) RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples. Cancer Genetics 274-275, pages 59-71.
Crossref
Xiaolei Cui, Yingping Tian, Yapei Zhao, Hengbo Gao, Dongqi Yao, Liang Liu & Yongjun Li. (2022) miR-199b-5p-AKAP1-DRP1 Pathway Plays a Key Role in ox-LDL-induced Mitochondrial Fission and Endothelial Apoptosis. Current Pharmaceutical Biotechnology 23:13, pages 1612-1622.
Crossref
Jingxing Liu, Shuyuan Xiao & Jing Chen. (2022) Development of an Inflammation-Related lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Breast Cancer at Single-Cell Resolution. Frontiers in Cell and Developmental Biology 10.
Crossref
Gaoting Qu, Tiantian He, Aisuo Dai, Yajie Zhao, Dian Guan, Shanwen Li, Huimin Shi, Weihua Gan & Aiqing Zhang. (2021) miR‑199b‑5p mediates adriamycin‑induced podocyte apoptosis by inhibiting the expression of RGS10. Experimental and Therapeutic Medicine 22:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.